Clinic
Medical Center of the Rockies
Medical Center of the Rockies was paid $1.84M by Medicaid between Feb 2019 and Dec 2024, across 34 billing codes. Its largest line is 99283, emergency room visit (moderate) — 81% of everything it billed.
33Billing provider infoMEDICAL CENTER OF THE ROCKIES
GREELEY, CO 80634
GREELEY, CO 80634
33aNPI1104262286assigned 05/16/2013
33bProvider typeEmergency Care Clinic/Center
28Total paid$1.84M
24GClaims25,048
24DCodes billed34
24AFirst – last monthFeb 2019 – Dec 2024
Compared with peers
Next to other Emergency Care Clinic/Center providers in Colorado
Rank by total paid#9 of 23
Median peer was paid$1.29M
This provider vs. median1.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official THOMPSON, DAVID controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 288 | $19K | |
| 2020 | 1,667 | $88K | |
| 2021 | 4,533 | $332K | |
| 2022 | 9,109 | $662K | |
| 2023 | 6,669 | $528K | |
| 2024incomplete | 2,782 | $214K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 81% | 11,836 | 10,934 | $1.50M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 6.4% | 928 | 854 | $117K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 5.4% | 1,259 | 1,179 | $100K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.2% | 904 | 782 | $77K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 51 | 51 | $18K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 148 | 146 | $12K |
| 80047 | <1% | 1,205 | 1,115 | $8K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 63 | 53 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 50 | 39 | $3K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 131 | 111 | $537.06 |
| J3490 | Unclassified drugs | <1% | 5,579 | 3,756 | $476.37 |
| 80053 | Comprehensive metabolic panel | <1% | 14 | 14 | $462.80 |
22 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 21 | $413.19 |
| 85027 | <1% | 1,156 | $183.46 | |
| 81003 | <1% | 665 | $100.74 | |
| 71045 | Radiologic examination, chest; single view | <1% | 12 | $55.97 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 349 | $15.80 |
| 82977 | 0% | 14 | $0.00 | |
| 84155 | 0% | 14 | $0.00 | |
| 82247 | 0% | 14 | $0.00 | |
| 81025 | 0% | 64 | $0.00 | |
| 84460 | 0% | 14 | $0.00 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 56 | $0.00 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 29 | $0.00 |
| 84450 | 0% | 14 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 12 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 135 | $0.00 |
| J8597 | Antiemetic drug, oral, not otherwise specified | 0% | 13 | $0.00 |
| 81001 | 0% | 36 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 182 | $0.00 |
| 82150 | 0% | 14 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 38 | $0.00 |
| 84075 | 0% | 14 | $0.00 | |
| 82040 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHOMPSON, DAVID (CFO)
Parent organizationMEDICAL CENTER OF THE ROCKIES
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.